List of Shenyang Pharmaceutical University patents

List of Shenyang Pharmaceutical University patents

List of Rapid Pathogen Screening patents

List of Bidgely patents

List of Polar Electro patents

List of companies in Mario Götze's investment portfolio

List of companies in iVision Ventures's investment portfolio

Patents where

Current Assignee

Name

is

Shenyang Pharmaceutical University

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 8349835 Aromatic ring fused triazine derivatives and uses thereof	Patent 8349835 was granted and assigned to Shenyang Pharmaceutical University on January, 2013 by the United States Patent and Trademark Office.		Shenyang Pharmaceutical University		United States Patent and Trademark Office	8349835	January 8, 2013
	‌ US Patent 9783499 Quinoline derivatives and their applications	Patent 9783499 was granted and assigned to Shenyang Pharmaceutical University on October, 2017 by the United States Patent and Trademark Office.	Shenyang Pharmaceutical University	Shenyang Pharmaceutical University		United States Patent and Trademark Office	9783499	October 10, 2017
	‌ US Patent 11155820 Target of VGSC β3 protein for prevention, treatment and diagnostic detection of cancers	Patent 11155820 was granted and assigned to Shenyang Pharmaceutical University on October, 2021 by the United States Patent and Trademark Office.	Shenyang Pharmaceutical University	Shenyang Pharmaceutical University		United States Patent and Trademark Office	11155820	October 26, 2021
	‌ US Patent 9718837 Nitrogen-containing heterocyclic ring substituted dihydroartemisinin derivatives and use thereof	Patent 9718837 was granted and assigned to Shenyang Pharmaceutical University on August, 2017 by the United States Patent and Trademark Office.	Shenyang Pharmaceutical University	Shenyang Pharmaceutical University		United States Patent and Trademark Office	9718837	August 1, 2017
	‌ US Patent 7592309 Method of using a peptide having analgesic and antitumor activity from scorpion	Patent 7592309 was granted and assigned to Shenyang Pharmaceutical University on September, 2009 by the United States Patent and Trademark Office.		Shenyang Pharmaceutical University		United States Patent and Trademark Office	7592309	September 22, 2009
	‌ US Patent 9127075 Analgesic active peptide VGG, preparation and use thereof	Patent 9127075 was granted and assigned to Shenyang Pharmaceutical University on September, 2015 by the United States Patent and Trademark Office.		Shenyang Pharmaceutical University		United States Patent and Trademark Office	9127075	September 8, 2015
	‌ US Patent 8877949 Furo[3,2-g]chromene compounds and uses thereof	Patent 8877949 was granted and assigned to Shenyang Pharmaceutical University on November, 2014 by the United States Patent and Trademark Office.		Shenyang Pharmaceutical University		United States Patent and Trademark Office	8877949	November 4, 2014
	‌ US Patent 8415505 2-methylene-5-substituted-methylenecyclopentanone derivatives and use thereof	Patent 8415505 was granted and assigned to Shenyang Pharmaceutical University on April, 2013 by the United States Patent and Trademark Office.		Shenyang Pharmaceutical University		United States Patent and Trademark Office	8415505	April 9, 2013
	‌ US Patent 7960427 5-hydroxyindole-3-carboxylate derivatives and uses thereof	Patent 7960427 was granted and assigned to Shenyang Pharmaceutical University on June, 2011 by the United States Patent and Trademark Office.		Shenyang Pharmaceutical University		United States Patent and Trademark Office	7960427	June 14, 2011

9 results

0 selected

9 results

0 selected